Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 843, 226-232
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81200399)
- Natural Science Foundation of Guangdong Province (2016A030313598)
This publication has 43 references indexed in Scilit:
- IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activityBlood, 2012
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- Blockade of Notch Ligand Delta1 Promotes Allograft Survival by Inhibiting Alloreactive Th1 Cells and Cytotoxic T Cell GenerationThe Journal of Immunology, 2011
- Type I-IFNs control GVHD and GVL responses after transplantationBlood, 2011
- Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseBlood, 2011
- Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow TransplantTransplantation and Cellular Therapy, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host DiseaseJournal of Clinical Oncology, 2008
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999